Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study

INTRODUCTION: Evidences of biologics-free disease control after discontinuing adalimumab (ADA) in rheumatoid arthritis (RA) patients in clinical practice have not been sufficiently investigated. Purpose of this study is to investigate whether disease activity score 28 (DAS28)- erythrocyte sedimentat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hirata, Shintaro, Saito, Kazuyoshi, Kubo, Satoshi, Fukuyo, Shunsuke, Mizuno, Yasushi, Iwata, Shigeru, Nawata, Masao, Sawamukai, Norifumi, Nakano, Kazuhisa, Yamaoka, Kunihiro, Tanaka, Yoshiya
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978613/
https://ncbi.nlm.nih.gov/pubmed/24286472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4315
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller